Investor Update

Basel, 25 March 2013

Actemra, a Treatment for Rheumatoid Arthritis Obtained Approval for Subcutaneous Injection Formulation

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.